Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
16 amino acids near the amino terminus of human CIITA. Source: Synthetic (Accession #: P33076) The CIITA Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-049635 |
| Réf. fabricant | 18295244 |
| Gene ID (Entrez) | 4261 |
| Famille de protéines | CIITA |
| Nom usuel | CIITA Blocking Peptide |
| Concentration | 0.2 mg/mL |
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
| À utiliser avec (application) | Antibody Competition |
| Alias de gène | C2TA, C2TAMHC class II transactivator type III, CIITAIV, class II, major histocompatibility complex, transactivator, MHC class II transactivator, MHC2TANLR family, acid domain containing, NLRA, nucleotide-binding oligomerization domain, leucine rich repea |
| Symbole de gène(s) | CIITA |
| Type d’étiquette | Unlabeled |
| Type de produit | Recombinant Protein |
| Quantité | 0.05 mg |
| État réglementaire | RUO |
| Source | Synthetic |
